Literature DB >> 20224266

Genetic alterations at 13q14 may correlate with differences in the biological behavior of prostate cancer between Japanese and Caucasian men.

Taku Misumi1, Yoshiaki Yamamoto, Tomoyuki Murakami, Yoshihisa Kawai, Hideaki Ito, Satoshi Eguchi, Seiji Yano, Kazuhiro Nagao, Takahiko Hara, Shigeru Sakano, Katsusuke Naito, Kohsuke Sasaki, Claudius Fuellhase, Luis Arenas, Jan Fichtner, Hideyasu Matsuyama.   

Abstract

The incidence of prostate cancer and the resultant mortality rates in Japanese men are lower compared with the rates for Caucasians; however, the Gleason score at diagnosis is higher in Japanese men compared with Caucasians. Loss of 13q is one of the most common chromosomal alterations in prostate cancer. To elucidate the difference in the rate of loss of 13q between Japanese and Caucasian men, we examined the allelic imbalance (AI) on chromosome 13q in 32 Japanese and 39 German prostate cancer patients with a fluorescent polymerase chain reaction technique using 12 microsatellite markers. Benign and malignant histology was identified by a single pathologist and laser capture microdissection was used to gather cancer cells. Although there were no statistical differences in patient background characteristics, the frequency of AI at 13q14 (D13S1253) and at 13q21 (D13S166) was significantly higher in Japanese patients compared with German patients (p = 0.0128 and p = 0.0078, respectively). The frequency of AI at 13q14 was significantly higher in tumors with high Gleason scores (GS) compared with tumors with low GS (p = 0.0478). The present observations suggest that the frequency of genetic alterations at 13q14 may underlie differences in the biological behavior of prostate cancer between Japanese and Caucasian populations. Copyright (c) 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20224266     DOI: 10.1159/000296291

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  4 in total

1.  Significance of docetaxel-based chemotherapy as treatment for metastatic castration-resistant prostate cancer in Japanese men over 75 years old.

Authors:  Hideaki Miyake; Iori Sakai; Ken-ichi Harada; Mototsugu Muramaki; Masato Fujisawa
Journal:  Int Urol Nephrol       Date:  2012-06-24       Impact factor: 2.370

2.  Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Adenocarcinoma.

Authors:  Hyung Kyu Park; HyunKyung Kim; Hyeong-Gon Kim; Young Mee Cho; Woon Yong Jung; Hye Seung Han; Tae Sook Hwang; Ghee Young Kwon; So Dug Lim
Journal:  J Korean Med Sci       Date:  2015-04-15       Impact factor: 2.153

3.  Increased aPKC Expression Correlates with Prostatic Adenocarcinoma Gleason Score and Tumor Stage in the Japanese Population.

Authors:  Anthony S Perry; Bungo Furusato; Raymond B Nagle; Sourav Ghosh
Journal:  Prostate Cancer       Date:  2014-04-29

4.  Sites of synchronous distant metastases and prognosis in prostate cancer patients with bone metastases at initial diagnosis: a population-based study of 16,643 patients.

Authors:  Feng Zhao; Jili Wang; Meiqin Chen; Danni Chen; Sunyi Ye; Xinke Li; Xin Chen; Guoping Ren; Senxiang Yan
Journal:  Clin Transl Med       Date:  2019-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.